Delphine Denoyer

3.4k total citations · 3 hit papers
47 papers, 2.8k citations indexed

About

Delphine Denoyer is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Delphine Denoyer has authored 47 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 17 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Molecular Biology. Recurrent topics in Delphine Denoyer's work include Radiopharmaceutical Chemistry and Applications (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Trace Elements in Health (9 papers). Delphine Denoyer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Trace Elements in Health (9 papers). Delphine Denoyer collaborates with scholars based in Australia, France and Brazil. Delphine Denoyer's co-authors include Michael A. Cater, Shashank Masaldan, Sharon La Fontaine, S Clatworthy, Mark J. Smyth, John Stagg, Karen M. Dwyer, Janelle Sharkey, Upulie Divisekera and Sandra Pommey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Delphine Denoyer

47 papers receiving 2.7k citations

Hit Papers

Targeting copper in cance... 2010 2026 2015 2020 2015 2010 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting copper in cancer therapy: ‘Copper That Cancer’
    2015 660 citations Delphine Denoyer, Michael A. Cater et al. Metallomics profile →
  2. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
    2010 479 citations Delphine Denoyer et al. profile →
  3. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis
    2017 351 citations Delphine Denoyer, Michael A. Cater et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delphine Denoyer Australia 23 969 936 583 417 391 47 2.8k
Sumit Sahni Australia 35 1.1k 1.2× 1.9k 2.0× 331 0.6× 409 1.0× 61 0.2× 90 3.6k
Patric J. Jansson Australia 42 2.4k 2.4× 2.6k 2.8× 354 0.6× 466 1.1× 117 0.3× 85 5.5k
Dona Alberti United States 30 1.0k 1.1× 1.4k 1.5× 419 0.7× 387 0.9× 136 0.3× 90 2.8k
Carlo Leonetti Italy 41 1.8k 1.8× 3.2k 3.4× 353 0.6× 684 1.6× 202 0.5× 129 5.1k
Pierantonio Menna Italy 25 1.8k 1.8× 1.6k 1.7× 454 0.8× 244 0.6× 222 0.6× 65 4.8k
Emanuela Salvatorelli Italy 23 1.7k 1.8× 1.5k 1.6× 449 0.8× 241 0.6× 221 0.6× 56 4.7k
Francesca Bianchini Italy 38 1.3k 1.3× 2.4k 2.5× 394 0.7× 1.3k 3.2× 171 0.4× 118 4.7k
Michael Höpfner Germany 29 623 0.6× 1.2k 1.3× 419 0.7× 384 0.9× 126 0.3× 64 2.5k
Raymond P. Perez United States 31 1.7k 1.8× 1.2k 1.3× 339 0.6× 310 0.7× 217 0.6× 109 3.2k
Dennis Carney Australia 20 590 0.6× 1.7k 1.8× 208 0.4× 345 0.8× 197 0.5× 51 3.4k

Countries citing papers authored by Delphine Denoyer

Since Specialization
Citations

This map shows the geographic impact of Delphine Denoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Denoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Denoyer more than expected).

Fields of papers citing papers by Delphine Denoyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Denoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Denoyer. The network helps show where Delphine Denoyer may publish in the future.

Co-authorship network of co-authors of Delphine Denoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Denoyer. A scholar is included among the top collaborators of Delphine Denoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Denoyer. Delphine Denoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaodan, Hyun‐Jung Cho, Wenjia Lu, et al.. (2024). Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness. Pharmacological Research. 210. 107519–107519. 2 indexed citations
2.
Lane, Darius J.R., Scott Ayton, Richard P. Redvers, et al.. (2023). Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer. Cancers. 15(4). 1216–1216. 12 indexed citations
3.
Macdonald, Joanna, et al.. (2020). Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells. Nucleic Acid Therapeutics. 30(2). 117–128. 47 indexed citations
4.
Redvers, Richard P., Scott Ayton, Irmina Diala, et al.. (2019). Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis. Breast Cancer Research. 21(1). 94–94. 122 indexed citations
5.
Redvers, Richard P., Andrew J. Lucke, Robert C. Reid, et al.. (2018). Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis. Disease Models & Mechanisms. 11(7). 24 indexed citations
6.
Martin, Ana Carolina Baptista Moreno, Amanda Blanque Becceneri, James Almada da Silva, et al.. (2017). [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer in vivo. Oncotarget. 8(42). 72260–72271. 65 indexed citations
7.
Freestone, David, et al.. (2016). Ceruloplasmin is regulated by copper and lactational hormones in PMC42-LA mammary epithelial cell culture models. Metallomics. 8(9). 941–950. 5 indexed citations
8.
Denoyer, Delphine, Pavel Lobachevsky, Price Jackson, et al.. (2015). Analysis of 177Lu-DOTA-Octreotate Therapy–Induced DNA Damage in Peripheral Blood Lymphocytes of Patients with Neuroendocrine Tumors. Journal of Nuclear Medicine. 56(4). 505–511. 42 indexed citations
9.
Paterson, Brett M., Peter Roselt, Delphine Denoyer, et al.. (2013). PET imaging of tumours with a64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate. Dalton Transactions. 43(3). 1386–1396. 80 indexed citations
10.
Ma, Michelle, Oliver Neels, Delphine Denoyer, et al.. (2011). Gallium-68 Complex of a Macrobicyclic Cage Amine Chelator Tethered to Two Integrin-Targeting Peptides for Diagnostic Tumor Imaging. Bioconjugate Chemistry. 22(10). 2093–2103. 44 indexed citations
11.
Denoyer, Delphine, Johannes A. Eble, Richard P. Redvers, et al.. (2011). Integrin‐dependent response to laminin‐511 regulates breast tumor cell invasion and metastasis. International Journal of Cancer. 130(3). 555–566. 57 indexed citations
12.
Denoyer, Delphine, Ivan Greguric, Peter Roselt, et al.. (2010). High-Contrast PET of Melanoma Using 18F-MEL050, a Selective Probe for Melanin with Predominantly Renal Clearance. Journal of Nuclear Medicine. 51(3). 441–447. 46 indexed citations
13.
Denoyer, Delphine, et al.. (2006). Spectrum of Radiopharmaceuticals in Nuclear Oncology. Current Cancer Drug Targets. 6(3). 181–196. 8 indexed citations
14.
Perek, Nathalie, et al.. (2005). MRP-1 Protein Expression and Glutathione Content of In Vitro Tumor Cell Lines Derived from Human Glioma Carcinoma U-87-MG Do Not Interact with 99 mTc-Glucarate Uptake. Cancer Biotherapy and Radiopharmaceuticals. 20(4). 391–400. 9 indexed citations
15.
Perek, Nathalie, et al.. (2005). Study of Monoglutathionyl Conjugates TC-99MSestamibi and TC-99M-Tetrofosmin Transport Mediated by the Multidrug Resistance–Associated Protein Isoform 1 in Glioma Cells. Cancer Biotherapy and Radiopharmaceuticals. 20(3). 249–259. 14 indexed citations
16.
17.
18.
Denoyer, Delphine, et al.. (2003). The Multidrug Resistance of In Vitro Tumor Cell Lines Derived from Human Breast Carcinoma MCF-7 Does Not Influence Pentavalent Technetium-99m-Dimercaptosuccinic Acid Uptake. Cancer Biotherapy and Radiopharmaceuticals. 18(5). 791–801. 6 indexed citations
19.
Perek, Nathalie, Delphine Denoyer, Frédéric Dubois, & Françoise Koumanov. (2002). Malignant gliomas display altered plasma membrane potential and pH regulation--interaction with Tc-99m-MIBI and Tc-99m-Tetrofosmin uptakes.. PubMed. 21(4). 381–404. 14 indexed citations
20.
Perek, Nathalie, Françoise Koumanov, Delphine Denoyer, Delphine Boudard, & Francis Dubois. (2002). Modulation of the Multidrug Resistance of Glioma by Glutathione Levels Depletion - Interaction with TC-99M-Sestamibi and TC-99M-Tetrofosmin. Cancer Biotherapy and Radiopharmaceuticals. 17(3). 291–302. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumit Sahni Breakdown of academic impact, for papers by Patric J. Jansson Breakdown of academic impact, for papers by Dona Alberti Breakdown of academic impact, for papers by Carlo Leonetti Breakdown of academic impact, for papers by Pierantonio Menna Breakdown of academic impact, for papers by Emanuela Salvatorelli Breakdown of academic impact, for papers by Francesca Bianchini Breakdown of academic impact, for papers by Michael Höpfner Breakdown of academic impact, for papers by Raymond P. Perez Breakdown of academic impact, for papers by Dennis Carney
Rankless by CCL
2026